BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/26/2024 8:53:40 AM | Browse: 19 | Download: 19
 |
Received |
|
2023-12-24 05:12 |
|
Peer-Review Started |
|
2023-12-24 05:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-01-19 01:02 |
|
Revised |
|
2024-01-24 01:06 |
|
Second Decision |
|
2024-04-01 01:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-04-01 02:01 |
|
Articles in Press |
|
2024-04-01 02:01 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-04-22 00:46 |
|
Publish the Manuscript Online |
|
2024-04-26 08:53 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Masaya Iwamuro, Seiji Kawano and Motoyuki Otsuka |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Masaya Iwamuro, MD, PhD, Assistant Professor, Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-Ku, Okayama 700-8558, Japan. pr145h2k@okayama-u.ac.jp |
| Key Words |
Diagnosis; Esophagogastroduodenoscopy; Non-neoplastic lesions; Esophageal lesions; Gastric lesions; Duodenal lesions |
| Core Tip |
Various lesions associated with medication use are detected during esophagogastroduodenoscopy, including pill-induced esophagitis, desquamative esophagitis, deteriorating gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet-induced gastric lesions, immune-related adverse event (irAE) gastritis, olmesartan-associated sprue-like enteropathy, duodenal pseudomelanosis, and lanthanum deposition. Endoscopists must diagnose these mucosal alterations by acquiring pertinent knowledge regarding medication-induced lesions, concomitant with inquiries concerning patient medication history. |
| Publish Date |
2024-04-26 08:53 |
| Citation |
Iwamuro M, Kawano S, Otsuka M. Drug-induced mucosal alterations observed during esophagogastroduodenoscopy. World J Gastroenterol 2024; 30(16): 2220-2232 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i16/2220.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i16.2220 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
